MSDC-5514 - a novel insulin sensitizer to treat diabetes and nonalcoholic steatohepatitis June 28, 2018
Part A data from phase III HOPE study of voxelotor in sickle cell disease show primary endpoint met June 28, 2018
Results presented for KEYNOTE-046 study of ADXS-PSA plus pembrolizumab in patients with mCRPC June 28, 2018
Preliminary data from phase Ib/II study of PCM-075 in combination with cytarabine or decitabine June 28, 2018
RSS